Davis Selected Advisers lessened its position in Solventum Co. (NYSE:SOLV - Free Report) by 0.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,246,614 shares of the company's stock after selling 24,899 shares during the quarter. Solventum accounts for approximately 2.0% of Davis Selected Advisers' portfolio, making the stock its 18th largest holding. Davis Selected Advisers owned about 3.04% of Solventum worth $346,591,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Modus Advisors LLC purchased a new position in shares of Solventum during the fourth quarter valued at approximately $25,000. Stonebridge Financial Group LLC bought a new stake in shares of Solventum during the fourth quarter valued at approximately $26,000. Crews Bank & Trust bought a new stake in Solventum in the 4th quarter worth approximately $32,000. True Wealth Design LLC grew its position in Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company's stock worth $33,000 after purchasing an additional 471 shares during the period. Finally, Prospera Private Wealth LLC bought a new stake in Solventum in the 3rd quarter worth approximately $35,000.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on SOLV shares. Wells Fargo & Company lifted their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Bank of America lifted their price target on shares of Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 26th. The Goldman Sachs Group lifted their price target on shares of Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a research note on Monday, March 3rd. Morgan Stanley lifted their price target on shares of Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th. Finally, Piper Sandler lifted their price target on shares of Solventum from $75.00 to $84.00 and gave the stock a "neutral" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Solventum has an average rating of "Hold" and a consensus price target of $79.86.
Get Our Latest Analysis on SOLV
Solventum Price Performance
Shares of SOLV traded down $1.94 during trading hours on Wednesday, reaching $73.95. 1,042,167 shares of the stock traded hands, compared to its average volume of 1,438,568. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $85.92. The company's 50-day moving average price is $74.08 and its two-hundred day moving average price is $70.94. The company has a market cap of $12.79 billion and a P/E ratio of 26.89.
About Solventum
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Recommended Stories

Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.